No Data
No Data
No Data
No Data
No Data
Trading Halt: Halt Status Updated at 9:00:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halt Status Updated at 9:00:00 AM ET: Quotation Resumption: News and Resumption Times
BenzingaApr 4 21:00
EFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined With Pembrolizumab in Non-Small Cell Lung Cancer
Yahoo FinanceApr 4 20:30
Trading Halt: Halted at 8:25:00 A.m. ET - Trading Halt: Halt News Pending
Trading Halt: Halted at 8:25:00 A.m. ET - Trading Halt: Halt News Pending
BenzingaApr 4 20:25
Trading Halt: Halt Status Updated at 9:10:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halt Status Updated at 9:10:00 AM ET: Quotation Resumption: News and Resumption Times
BenzingaJan 12 22:10
EFFECTOR Therapeutics (NASDAQ:EFTRW) Shares Down 13.1%
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) traded down 13.1% on Wednesday . The company traded as low as $0.10 and last traded at $0.12. 898 shares traded hands during trading, a decline
Defense WorldApr 20, 2023 15:26
EFFECTOR Therapeutics (NASDAQ:EFTRW) Trading Up 21.4%
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) shot up 21.4% on Wednesday . The stock traded as high as $0.17 and last traded at $0.16. 1,403 shares changed hands during mid-day trading, a de
Defense WorldMar 9, 2023 15:41
No Data
No Data